---
title: "How Does Saxenda® Work? A Clinical Deep-Dive | HealthRX.com"
description: "Saxenda activates GLP-1 receptors; its label calls GLP-1 a regulator of appetite and says Saxenda delays gastric emptying. It is a once-daily injection."
url: https://healthrx.com/glp-1-faq/how-does-saxenda-work-calibrate
publisher: HealthRX.com
---


HealthRX.com

Saxenda activates GLP-1 receptors and slows stomach emptying

[Print or save as PDF](https://healthrx.com/printables/glp-1-faq/how-does-saxenda-work-calibrate?print=1)

Key numbers

- 8.4 kg Mean weight loss on liraglutide 3 mg over 56 weeks, vs 2.8 kg on placebo Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26132939/), as cited Nov 7, 2026
- 63.2% Adults on liraglutide 3 mg losing at least 5% of body weight in 56 weeks (placebo 27.1%) Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26132939/), as cited Nov 7, 2026
- 16 weeks First weight check; stop if less than 4% of baseline body weight is lost Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143), as cited Nov 7, 2026
- 13 hours Plasma half-life of liraglutide after injection, vs 1.5 to 2 minutes for native GLP-1 Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143), as cited Nov 7, 2026

[See the public record for Liraglutide](https://healthrx.com/data/liraglutide)

HealthRX.com quick answer. Saxenda is a once-daily liraglutide injection that works as a GLP-1 receptor agonist: it activates receptors for glucagon-like peptide-1, which the label describes as a physiological regulator of appetite and calorie intake, and it delays gastric emptying [1]. In the 56-week SCALE Obesity and Prediabetes trial, adults on liraglutide 3 mg lost a mean 8.4 kg versus 2.8 kg on placebo, and 63.2% versus 27.1% lost at least 5% of body weight [2].

At a glance

- Drug / liraglutide 3 mg once daily (Saxenda) [1]
- Class / GLP-1 receptor agonist [1]
- Labeled mechanism / GLP-1 receptor activation plus delayed gastric emptying [1]
- Half-life / about 13 hours after subcutaneous injection [1]
- Adult dose / 3 mg daily, reached at week 5 by stepping up from 0.6 mg [1]
- First response check / 16 weeks; the label says to stop if less than 4% of baseline weight is lost [1]
- Common GI effects / nausea 39.3% vs 13.8% placebo; diarrhea 20.9% vs 9.9% [1]
- Boxed warning / thyroid C-cell tumors in rodents; human relevance unknown [1]

## What Is Saxenda and What Does It Do?

Saxenda is liraglutide at 3 mg daily, a GLP-1 receptor agonist approved with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight loss long term in adults with obesity, or adults with overweight and at least one weight-related comorbid condition, and in children aged 12 years and older who weigh more than 60 kg and have obesity [1]. The label says not to combine Saxenda with other liraglutide products or any other GLP-1 receptor agonist [1].

## How the Molecule Works

Liraglutide is an acylated human GLP-1 receptor agonist with 97% amino acid sequence homology to endogenous GLP-1(7-37) [1]. It is stable against DPP-4 and neutral endopeptidase degradation, and its plasma half-life is 13 hours after subcutaneous injection, compared with 1.5 to 2 minutes for native GLP-1 [1]. In early work on GLP-1 derivatives, attaching fatty acids protracted action by facilitating binding to serum albumin [3]. That gap between 13 hours and about two minutes is what separates liraglutide from the body's own GLP-1 among [GLP-1 weight loss medicines](https://healthrx.com/weight-loss).

The label describes GLP-1 as a physiological regulator of appetite and calorie intake and notes that GLP-1 receptors are present in brain areas involved in appetite regulation. It also states that Saxenda delays gastric emptying [1].

After subcutaneous injection, peak concentration is about 11 hours, absolute bioavailability about 55%, and more than 98% is protein bound [1]. It is metabolized like a large protein, without a specific organ of elimination, and intact drug is not found in urine or feces [1].

What people on Reddit report

These are Reddit accounts from r/liraglutide where people on liraglutide discuss how the drug works, with some crediting appetite and others crediting slower stomach emptying or insulin effects.

mistadong · liraglutide

GLP-1 will slow gastric emptying, so your stomach fills up faster and you get full faster

Commenter lists several mechanisms, including slowed stomach emptying, hunger hormone balance, and insulin and glucose effects.

[Read the source discussion](https://www.reddit.com/r/liraglutide/comments/zqc4bl/how_exactly_does_saxenda_work/)

fearedfurnacefighter · liraglutide

For me, it is definitely the appetite suppressant that is making the difference.

Commenter says reduced appetite is what made the difference for them and that their food intake dropped sharply.

[Read the source discussion](https://www.reddit.com/r/liraglutide/comments/w57o6q/how_saxenda_really_works/)

melizerd · liraglutide

Appetite suppression isn't the main way this medication works.

Commenter argues appetite suppression is a side result of slowed stomach emptying rather than the main mechanism.

[Read the source discussion](https://www.reddit.com/r/liraglutide/comments/w57o6q/how_saxenda_really_works/)

melizerd · liraglutide

Slowing gastric emptying is part of how the medication works. It also works in the pancreas so that you more efficiently use insulin.

Commenter on the drug says it works partly by slowing stomach emptying and partly by helping the body use insulin more efficiently.

[Read the source discussion](https://www.reddit.com/r/liraglutide/comments/1678ov6/question_about_how_weight_loss_actually_works_on/)

Questions worth asking

Choose the questions you want to keep How does slowed stomach emptying affect how full I feel after meals? Is the mechanism of Saxenda mainly appetite reduction or something else? Does the GLP-1 receptor activation in Saxenda act in the brain as well as the gut? How might Saxenda's effect on insulin matter if I do not have diabetes? What signs of pancreatitis or gallbladder problems should I report while on Saxenda? How long after starting Saxenda should I expect the mechanism to start working?

## Why the Dose Goes Up Slowly

Saxenda starts at 0.6 mg once daily for 1 week, then increases weekly to 1.2 mg, 1.8 mg, 2.4 mg, and 3 mg from week 5 [1]. The label gives 3 mg daily as the recommended adult dose, says lower doses are for titration only, and says to discontinue Saxenda if the 3 mg dose is not tolerated [1]. The label ties the step-up schedule to reducing gastrointestinal adverse reactions [1]. If more than 3 days pass without a dose, the label says to restart at 0.6 mg and re-titrate [1].

## Results from the liraglutide obesity and prediabetes trial

In SCALE Obesity and Prediabetes, 3,731 adults without [type 2 diabetes](https://healthrx.com/conditions-type-2-diabetes/diagnosis-algorithm) with a BMI of at least 30, or at least 27 with dyslipidemia or hypertension, received liraglutide 3 mg (2,487 people) or placebo (1,244 people) plus lifestyle counseling for 56 weeks [2]. The paper reported mean weight loss of 8.4 kg with liraglutide versus 2.8 kg with placebo, a difference of 5.6 kg; 63.2% versus 27.1% lost at least 5% of body weight, and 33.1% versus 10.6% lost more than 10% [2]. The label reports the same trial with a different analysis: a 7.4% versus 3.0% body-weight change, and 62.3% versus 34.4% losing at least 5% [1].

In SCALE Diabetes, 846 adults with overweight or [obesity and type 2 diabetes](https://healthrx.com/conditions-obesity/comorbidities) received liraglutide 3 mg, liraglutide 1.8 mg, or placebo for 56 weeks [4]. Weight loss was 6.0% with 3 mg, 4.7% with 1.8 mg, and 2.0% with placebo [4]. In SCALE Maintenance, 422 adults who had already lost at least 5% of body weight during a low-calorie diet run-in lost an additional mean 6.2% with liraglutide versus 0.2% with placebo over 56 weeks [5].

## Common reactions and warnings on Saxenda

The most common adverse reaction is nausea: 39.3% with Saxenda versus 13.8% with placebo in adult trials [1]. Diarrhea occurred in 20.9% versus 9.9%, constipation in 19.4% versus 8.5%, vomiting in 15.7% versus 3.9%, and dyspepsia in 9.6% versus 2.7% [1]. About 68% versus 39% reported any gastrointestinal disorder, and nausea declined as treatment continued [1]. Discontinuation for adverse reactions was 9.8% versus 4.3% [1].

The label lists warnings for acute pancreatitis, acute gallbladder disease, hypoglycemia when combined with insulin or a sulfonylurea, heart rate increase, acute kidney injury from volume depletion, severe gastrointestinal adverse reactions (not recommended in severe gastroparesis), hypersensitivity, and pulmonary aspiration during general anesthesia or deep sedation [1]. The label says to discontinue Saxenda if pancreatitis is suspected [1]. The boxed warning is about thyroid C-cell tumors in rats and mice; human relevance is unknown, and Saxenda is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2 [1]. Routine calcitonin or thyroid ultrasound monitoring is of uncertain value, according to the label [1].

Heart rate: mean [resting heart rate](https://healthrx.com/labs-resting-hr/what-it-measures) rose 2 to 3 beats per minute; more patients had changes of more than 10 beats per minute at two consecutive visits (34% versus 19%), and at least one resting heart rate above 100 beats per minute was recorded in 6% versus 4% [1]. The label says to monitor heart rate at regular intervals [1]. Gallbladder events: cholelithiasis 2.2% versus 0.8%, cholecystitis 0.8% versus 0.4% [1]. In adults with type 2 diabetes taking a sulfonylurea, glucose below 54 mg/dL occurred in 28.2% on Saxenda versus 12.7% on placebo [1].

## Who Is It For?

The label's adult indication is obesity, or overweight with at least one weight-related comorbid condition [1]. The pediatric indication is age 12 and older, body weight greater than 60 kg, and obesity [1]. The label says to evaluate weight at 16 weeks and stop if the patient has not lost at least 4% of baseline body weight [1]. Contraindications are a personal or family history of medullary thyroid carcinoma or MEN 2, and serious hypersensitivity to liraglutide or an excipient [1].

The current label does not list pregnancy as a formal contraindication. It says Saxenda should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, that weight loss offers no benefit in pregnancy, and that Saxenda should be discontinued when pregnancy is recognized [1].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, at what week does the Saxenda dose reach 3 mg daily?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Printable titration log

Saxenda dose step-up and response tracking sheet

Use this sheet to track each weekly Saxenda dose step-up, missed or delayed injections, and the weight and side effect notes to review at your prescriber or pharmacist visits.

[Open the fill-in sheet](https://healthrx.com/printables/glp-1-faq/how-does-saxenda-work-calibrate) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

How does Saxenda work for weight loss?

Saxenda activates the GLP-1 receptor and delays gastric emptying [1]. In the 56-week SCALE Obesity and Prediabetes trial, adults on liraglutide 3 mg lost a mean 8.4 kg versus 2.8 kg on placebo [2].

How long does Saxenda take to work?

The label sets the first formal response check at 16 weeks, when it says to stop Saxenda if the patient has not lost at least 4% of baseline body weight [1].

What is the Saxenda dosing schedule?

The labeled dosing schedule is 0.6 mg once daily for 1 week, followed by weekly increases to 1.2 mg, 1.8 mg, 2.4 mg, and 3 mg from week 5 [1]. The recommended adult dose is 3 mg daily, and lower doses are for titration only [1].

What are the most common side effects of Saxenda?

Nausea occurred in 39.3% versus 13.8% on placebo, diarrhea in 20.9% versus 9.9%, constipation in 19.4% versus 8.5%, and vomiting in 15.7% versus 3.9% [1]. About 68% versus 39% reported any gastrointestinal disorder, and nausea declined as treatment continued [1].

Is Saxenda the same as Victoza?

No. Saxenda and Victoza are separate Novo Nordisk products, both once-daily liraglutide injections, approved for different uses. Saxenda is for chronic weight management, with a recommended adult dose of 3 mg daily [1]. Victoza is for type 2 diabetes, with a maximum adult dose of 1.8 mg daily, and is not approved for weight loss.

Can people with type 2 diabetes use Saxenda?

Saxenda is approved for weight management and is not indicated for glycemic control [1]. In SCALE Diabetes, 846 adults with overweight or obesity and type 2 diabetes lost 6.0% on liraglutide 3 mg, 4.7% on 1.8 mg, and 2.0% on placebo at 56 weeks [4]. The label warns about hypoglycemia when Saxenda is combined with insulin or a sulfonylurea [1].

References

Show all 8 references Hide references

1. U.S. National Library of Medicine, DailyMed. Saxenda injection (liraglutide) prescribing information. [Saxenda injection (liraglutide) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
2. Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. [A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management](https://pubmed.ncbi.nlm.nih.gov/26132939/). N Engl J Med. 2015;373(1):11-22.
3. Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, et al. [Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration](https://pubmed.ncbi.nlm.nih.gov/10794683/). J Med Chem. 2000;43(9):1664-9.
4. Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, et al. [Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial](https://pubmed.ncbi.nlm.nih.gov/26284720/). JAMA. 2015;314(7):687-99.
5. Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, et al. [Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study](https://pubmed.ncbi.nlm.nih.gov/23812094/). Int J Obes (Lond). 2013;37(11):1443-51.
6. Reddit participants. [How exactly does saxenda work? (r/liraglutide)](https://www.reddit.com/r/liraglutide/comments/zqc4bl/how_exactly_does_saxenda_work/). Accessed 2026-11-10.
7. Reddit participants. [How Saxenda really works? (r/liraglutide)](https://www.reddit.com/r/liraglutide/comments/w57o6q/how_saxenda_really_works/). Accessed 2026-11-10.
8. Reddit participants. [Question about how weight loss ACTUALLY works on Saxenda vs. doing it without meds? + Worried about how little I am eating? (r/liraglutide)](https://www.reddit.com/r/liraglutide/comments/1678ov6/question_about_how_weight_loss_actually_works_on/). Accessed 2026-11-10.

Next in this cluster

Related reading

- [liraglutide Liraglutide regulatory status](https://healthrx.com/liraglutide-generic/regulatory-status-global)
- [saxenda Saxenda: Complete Guide to Liraglutide 3 mg for Weight Loss](https://healthrx.com/glp-1/saxenda)
- [liraglutide Saxenda side effects](https://healthrx.com/reviews-saxenda/side-effect-reports)
- [liraglutide Liraglutide: Uses, Doses, Side Effects, and How It Compares to Semaglutide and Tirzepatide](https://healthrx.com/glp-1/liraglutide)
- [tirzepatide GLP-1 impulse control](https://healthrx.com/glp-1-faq/how-glp-1-s-like-semaglutide-help-with-impulse-control)
- [zepbound vs mounjaro Zepbound vs Mounjaro](https://healthrx.com/glp-1-faq/how-is-zepbound-different-from-mounjaro-if-they-have-the-same-ingredient-calibra)
- [tirzepatide Mounjaro cost without insurance](https://healthrx.com/glp-1-faq/how-much-is-mounjaro-without-insurance-cost-of-tirzepatide-calibrate)
- [mounjaro vs trulicity Mounjaro weight loss](https://healthrx.com/glp-1-faq/how-much-more-effective-is-mounjaro-than-trulicity-for-weight-loss-calibrate)
- [glp 1 receptor agonists How to inject Ozempic](https://healthrx.com/glp-1-faq/how-to-inject-ozempic-semaglutide-guide-to-administering-glp-1s-calibrate-calibr)
- [muscle loss How to Prevent Muscle Loss on GLP-1 Medications](https://healthrx.com/glp-1-faq/how-to-prevent-muscle-loss-on-glp-1-medications)
- [semaglutide Is Wegovy Covered by Insurance?](https://healthrx.com/glp-1-faq/is-wegovy-covered-by-insurance-calibrate)
- [liraglutide Liraglutide side effects](https://healthrx.com/glp-1-faq/what-are-common-side-effects-of-saxenda-calibrate)
- [liraglutide Saxenda regulatory status](https://healthrx.com/saxenda/regulatory-status-global)
- [wegovy vs zepbound Wegovy vs Zepbound: Cost and Access Head-to-Head Comparison](https://healthrx.com/compare-glp-1/wegovy-vs-zepbound--cost-access)

![how saxenda works: woman starting daily morning routine beside nightstand with water](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/glp-1-faq/how-does-saxenda-work-calibrate.webp)

A once-daily medicine fits into a consistent morning routine, which matters because dosing steps up slowly over weeks. Full Saxenda guide and sources at [healthrx.com/glp-1-faq](https://healthrx.com/glp-1-faq).
